Latest News

TV ads must trumpet drug prices, Trump administration says. Pharma tries a Plan B.


 

On the question of whether requiring drug prices be listed in advertising violates the First Amendment’s free-speech guarantee, Corn-Revere said it “all comes down to the specifics.”

Mr. Ubl, when asked earlier about legal action, didn’t rule out the possibility. “We believe there are substantial statutory and constitutional principles that arise” from requiring list-price disclosure, Mr. Ubl said, adding: “We do have concerns about that approach.”

KHN’s coverage of prescription drug development, costs and pricing is supported in part by the Laura and John Arnold Foundation. Kaiser Health News is a nonprofit national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation that is not affiliated with Kaiser Permanente.

Pages

Recommended Reading

The patient who doesn’t like you
MDedge Family Medicine
Employer health insurance: Deductibles rising faster than wages
MDedge Family Medicine
Telehealth: States broaden options for locations, providers
MDedge Family Medicine
Half of outpatient antibiotics prescribed with no infectious disease code
MDedge Family Medicine
Anxiety and depression widespread among arthritis patients
MDedge Family Medicine
Bias in the clinical setting can impact patient care
MDedge Family Medicine
Tech-based cancer company raises access concerns
MDedge Family Medicine
Feds say ACA’s silver plan premiums will drop in 2019
MDedge Family Medicine
Early childhood developmental screening differs in the U.S., Scandinavia
MDedge Family Medicine
MedPAC eyes ‘incident to’ billing
MDedge Family Medicine